Tag Archives: Biogen

Congressional Report Finds FDA Ignored Agency Protocols in Approving Biogen’s Aduhelm Alzheimer’s Drug

December 30, 2022 By: Irvin Jackson

Biogen and FDA held numerous improperly documented meetings designed to drag Aduhelm through the approval process despite a lack of evidence showing the drug worked, the report found
FDA System For Approving New Drugs Found Lacking By Study

September 24, 2021 By: Irvin Jackson
Lawmakers Demand FDA Documents on Aduhelm Approval

September 03, 2021 By: Irvin Jackson
Investigation Into Alzheimer’s Drug Approval Process Requested By Multiple Entities, Including FDA

July 12, 2021 By: Irvin Jackson
Two FDA Advisory Committee Members Quit Over Controversial Approval of New Alzheimer’s Drug

June 11, 2021 By: Russell Maas
Consumer Group Calls FDA Approval of New Alzheimer’s Drug “Reckless”

June 08, 2021 By: Irvin Jackson
Public Citizen Calls For Investigation Into Collaboration Between FDA and Biogen Over New Alzheimer’s Drug

December 15, 2020 By: Irvin Jackson
Tysabri PML Risk-Minimization Strategies Working, Study Finds

September 16, 2019 By: Martha Garcia
Zinbryta Brain Inflammation Risks Outweigh Benefits: EMA

May 22, 2018 By: Irvin Jackson
Zinbryta Risks Prevented Use As MS Drug, Despite Effectiveness of Treatment: Report

April 25, 2018 By: Irvin Jackson

MDL Sought For Lawsuits Over Ozempic, Wegovy, Mounjaro and Other GLP-1 Receptor Agonists (Posted 4 days ago)

A group of plaintiffs have asked a panel of federal judges to consolidate all lawsuits over Ozempic, Wegovy and Mounjaro stomach paralysis injuries before one judge for pretrial procedures.

Suboxone Settlements Failed to Compensate Users Left With Tooth Decay or Tooth loss (Posted 7 days ago)

Although Suboxone settlements have been paid to resolve antitrust violations, users who suffered damages due to tooth decay from Suboxone film must pursue individual product liability lawsuits

Bard 3DMax Hernia Mesh Lawsuit Set for Trial To Begin in April 2024 (Posted 8 days ago)

With thousands of Bard hernia mesh lawsuits pending in the federal court system, a fourth bellwether trial will be held in the spring, involving allegations that defects with Bard 3DMax caused painful and permanent injuries.

Tag Archives: Biogen

Congressional Report Finds FDA Ignored Agency Protocols in Approving Biogen’s Aduhelm Alzheimer’s Drug

FDA System For Approving New Drugs Found Lacking By Study

Lawmakers Demand FDA Documents on Aduhelm Approval

Investigation Into Alzheimer’s Drug Approval Process Requested By Multiple Entities, Including FDA

Two FDA Advisory Committee Members Quit Over Controversial Approval of New Alzheimer’s Drug

Consumer Group Calls FDA Approval of New Alzheimer’s Drug “Reckless”

Public Citizen Calls For Investigation Into Collaboration Between FDA and Biogen Over New Alzheimer’s Drug

Tysabri PML Risk-Minimization Strategies Working, Study Finds

Zinbryta Brain Inflammation Risks Outweigh Benefits: EMA

Zinbryta Risks Prevented Use As MS Drug, Despite Effectiveness of Treatment: Report

More Top Stories

Review A Case